Inventor · disambiguated record
Yefen Zou
Also filed as: ZOU YEFEN
7 granted patents·3 pending applications·36 citations·filing 2009–2022
81Inventor score
Top patents by PatentIndex Score
10 records- 0187US8466167B2Compounds and compositions as TLR activity modulatorsWU TOM YAO HSIANG·Filed 2009·Granted Jun 18, 2013·16 cites·26 claims
- 0284US9315530B2Adsorption of immunopotentiators to insoluble metal saltsSINGH MANMOHAN·Filed 2011·Granted Apr 19, 2016·7 cites·18 claims
- 0380US9365506B2Compounds and compositions as TLR2 agonistsWU TOM YAO-HSIANG·Filed 2014·Granted Jun 14, 2016·5 cites·18 claims
- 0477US8895577B2Compounds and compositions as TLR activity modulatorsWU TOM YAO-HSIANG·Filed 2013·Granted Nov 25, 2014·4 cites·20 claims
- 0576US8808703B2Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etcWU TOM YAO-HSIANG·Filed 2011·Granted Aug 19, 2014·4 cites·18 claims
- 0665US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0753US10098949B2Adsorption of immunopotentiators to insoluble metal saltsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 16, 2018·0 cites·14 claims
- 0852US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 0952US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1045US2020131474A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yefen Zou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →